Apyx Medical's Stock Price Is About To Have A Liposuction - $3 Price Target (65% Downside)
Thursday, February 21, 2019 10:43 AM EDT
Apyx sells J-Plasma technology that has failed every medical application, is now only targeted for two off-label cosmetic applications.
Apyx's new CEO, Charlie Goodwin, was allegedly engaged in fraudulent sales activities at Olympus/Gyrus.